Map of Africa showing the three TSISSA MEDICINES industrial hubs (Côte d'Ivoire, Angola and Kenya) and the countries attached to each, marked by their flag.
A pan-African pharmaceutical platform

Producing Africa's health, in Africa

From production to distribution, an integrated African pharmaceutical chain

Pan-African pharmaceutical company

Build today, impact tomorrow.

A healthier, stronger and sovereign Africa.

The project in figures
3
regional industrial hubs
1st
pilot country: Angola
Our purpose

Health in the service of African development

Tsissa Medicines has one ambition: to help build an African pharmaceutical industry able to meet the continent's health needs over the long term while contributing to global innovation.

Heal

Developing reliable, accessible health solutions.

Preserve

Making responsible use of resources, the environment and local areas.

Pass on

Developing African knowledge, skills and scientific capacity.

Our model

An integrated approach to pharmaceuticals

Four connected functions, from industrial development to institutional cooperation.

01

Manufacture

Progressively building local pharmaceutical manufacturing capacity.

02

Innovate

Mobilising research, technology and intellectual property.

03

Train

Contributing to the development of African pharmaceutical skills.

04

Cooperate

Building lasting partnerships with governments, universities, manufacturers and investors.

Our strategy

Four pillars, one standard

Quality

GMP standardsWHO standardsLocal regulatory requirementsQuality and traceability

Innovation

DigitalisationTraceabilityIndustrial technologiesIntellectual property

Training

Technology transferSkills transferAcademic partnershipsContinuing education

Environment

Responsible infrastructureEnergy and waterMaterialsEnvironmental efficiency
Pan-African presence

A pan-African ambition

Three industrial hubs structure the roll-out, each tied to a group of countries at different stages of progress.

TanzaniaW. SaharaDem. Rep. CongoSomaliaKenyaSudanChadSouth AfricaLesothoZimbabweBotswanaNamibiaSenegalMaliMauritaniaBeninNigerNigeriaCameroonTogoGhanaCôte d'IvoireGuineaGuinea-BissauLiberiaSierra LeoneBurkina FasoCentral African Rep.CongoGabonEq. GuineaZambiaMalawiMozambiqueAngolaBurundiMadagascarGambiaTunisiaAlgeriaEritreaMoroccoEgyptLibyaEthiopiaDjiboutiSomalilandUgandaRwandaS. SudanANGOLAANGOLAACTIVE HUBCÔTE D'IVOIRECÔTE D'IVOIREKENYAKENYA
Industrial hub Countries associated with the active hub In development Associated countries Other pipeline countries
Our three commitments

TSISSA Factories

Produce quality medicines as close as possible to the people who need them.

TSISSA Institute

Train, research and innovate.

TSISSA Campus

Grow talent and the ecosystem around the site.

Commitments

Our commitments

Local footprint

Contributing to the development of the regions where we operate.

Resources

Preserving water and natural resources.

Energy

Advancing energy efficiency and self-sufficiency.

Health

Designing environments that respect human health.

Traceability

Strengthening transparency on materials and processes.

Equity

Building an inclusive, responsible industry.

Transmission

Creating environments that foster knowledge and human development.

Seven commitments

A responsible reading of our industrial sites.

Building an African pharmaceutical industry together

Governments, institutions, manufacturers and investors: let us discuss opportunities to work together.

Head office
22 Rue Duret, 75016 Paris